Boston Scientific (BSX) Revenue & Earnings 2020-2026
Revenue, EBITDA, operating income, net income, EPS, and shares
Revenue & Profit
Revenue, EBITDA, operating income, net income, EPS, and shares across quarters
TTM Revenue
$21.00B
13.5%
Q. Revenue
$5.44B
TTM EBITDA
$5.57B
24.7%
TTM Op. Income
$4.15B
31.9%
Q. Op. Income
$1.18B
TTM Net Income
$3.67B
46.9%
Q. Net Income
$905.00M
EPS
$0.62
Shares Out.
$1.47B
0.7%
$21.00B in TTM revenue grew 13.5% YoY, reaching $5.44B last quarter. TTM EBITDA of $5.57B and TTM operating income of $4.15B show growth is flowing through to the bottom line. TTM net income of $3.67B means revenue is converting into profit.
TTM Revenue
Reveals whether the core business is growing or shrinking
Quarterly Revenue
Highlights seasonal patterns and short-term momentum
TTM EBITDA
Shows if underlying operating profitability is improving
Quarterly EBITDA
Tracks near-term operating profitability trends
TTM Operating Income
Smoothed operating profit over the past four quarters
Quarterly Operating Income
Profit from core operations before financing costs
TTM Net Income
The bottom line — is the company making more money?
Quarterly Net Income
Short-term profit after all expenses and taxes
EPS
Earnings per share — profit attributable to each share
Shares Outstanding
Declining means buybacks benefit remaining holders
